Opinion
Video
Author(s):
Turning the focus to ibrutinib-based therapy, Yuliya Linhares, MD, gives an overview of the RESONATE study.
Childhood Cancer Survivors May Experience Sooner Aging-Related Disease
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
Longer Imbruvica and Venclexta Treatment May Be Beneficial in R/R CLL
The Treatment Journey of a Patient with CLL
Calquence Combo May Improve Outcomes in Chronic Lymphocytic Leukemia
Brukinsa Shows Favorable Safety Profile Over Imbruvica in CLL